These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 35872180

  • 21. Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.
    Monschke M, Wagner KG.
    Pharmaceutics; 2020 Jun 11; 12(6):. PubMed ID: 32545270
    [Abstract] [Full Text] [Related]

  • 22. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
    Solanki NG, Kathawala M, Serajuddin ATM.
    J Pharm Sci; 2019 Dec 11; 108(12):3859-3869. PubMed ID: 31542437
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.
    Dahan A, Beig A, Ioffe-Dahan V, Agbaria R, Miller JM.
    AAPS J; 2013 Apr 11; 15(2):347-53. PubMed ID: 23242514
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.
    Wilson VR, Mugheirbi NA, Mosquera-Giraldo LI, Deac A, Moseson DE, Smith DT, Novo DC, Borca CH, Slipchenko LV, Edgar KJ, Taylor LS.
    Mol Pharm; 2021 Mar 01; 18(3):836-849. PubMed ID: 33539105
    [Abstract] [Full Text] [Related]

  • 27. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD, Pinto JF, Henriques J, Paiva AM.
    Mol Pharm; 2022 Jan 03; 19(1):51-66. PubMed ID: 34919407
    [Abstract] [Full Text] [Related]

  • 28. Miniaturized Measurement of Drug-Polymer Interactions via Viscosity Increase for Polymer Selection in Amorphous Solid Dispersions.
    Auch C, Harms M, Golitsyn Y, Reichert D, Mäder K.
    Mol Pharm; 2019 May 06; 16(5):2214-2225. PubMed ID: 30920843
    [Abstract] [Full Text] [Related]

  • 29. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M, Nakanishi R, Umesaki M, Kobayashi M, Minami K, Higashino H, Yamaguchi S, Yamashita S.
    Eur J Pharm Biopharm; 2020 Oct 06; 155():29-36. PubMed ID: 32771692
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS.
    Al-Obaidi H, Buckton G.
    AAPS PharmSciTech; 2009 Oct 06; 10(4):1172-7. PubMed ID: 19842041
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion.
    Juneja M, Mehtre K, Saini V, Singh R, Amate P, Kashyap M, Sangamwar AT.
    Drug Deliv Transl Res; 2024 Jun 05. PubMed ID: 38837117
    [Abstract] [Full Text] [Related]

  • 33. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
    Zhang S, Lee TWY, Chow AHL.
    Int J Pharm; 2019 Jan 30; 555():394-403. PubMed ID: 30513399
    [Abstract] [Full Text] [Related]

  • 34. Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.
    Nguyen HT, Van Duong T, Taylor LS.
    Mol Pharm; 2023 Mar 06; 20(3):1681-1695. PubMed ID: 36730186
    [Abstract] [Full Text] [Related]

  • 35. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K, Kyeremateng SO, Bartels M, Degenhardt M, Sadowski G.
    Eur J Pharm Biopharm; 2018 Mar 06; 124():147-157. PubMed ID: 29269154
    [Abstract] [Full Text] [Related]

  • 36. Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion.
    Vo AQ, Feng X, Zhang J, Zhang F, Repka MA.
    Int J Pharm; 2018 Oct 25; 550(1-2):216-228. PubMed ID: 30142354
    [Abstract] [Full Text] [Related]

  • 37. Concordance of vacuum compression molding with spray drying in screening of amorphous solid dispersions of itraconazole.
    Dhumal G, Treffer D, Polli JE.
    Int J Pharm; 2024 Apr 10; 654():123952. PubMed ID: 38417729
    [Abstract] [Full Text] [Related]

  • 38. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion. II: Rheological Analysis and Extrudability Testing.
    Solanki NG, Gumaste SG, Shah AV, Serajuddin ATM.
    J Pharm Sci; 2019 Sep 10; 108(9):3063-3073. PubMed ID: 31103788
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
    Xi H, Yang Z, Tatavarti A, Xu W, Fuerst J, Ormes J.
    Int J Pharm; 2019 Jan 10; 554():48-53. PubMed ID: 30236644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.